Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet treatment for managing HIV infection. This formula integrates three crucial antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the virus's ability to multiply within the body, remarkably lowering the viral load. For